• SRAX’s investor intelligence platform Sequire announces that Q2 2020 sales exceeded $2.5 million
• The platform has seen customer numbers swell to over 75 publicly listed companies, rising from 59 at start of year
• SRAX also announced its raise of $13 million through the sale of convertible debentures, equity warrants
• While also settling an outstanding secured term loan, proceeds from raise will be used to fuel Sequire’s rapid expansion plans

SRAX (NASDAQ: SRAX), a digital marketing pioneer focused on providing consumer data management services, announced that its investor intelligence platform, Sequire, has shown significant growth in the second quarter with sales exceeding $2.5 million (http://nnw.fm/ku3L4). Launched in its rebranded format during SRAX’s first quarter earnings announcement, Sequire has witnessed a sharp increase in customer interest in recent months, growing its client base to over 75 publicly traded companies in the US and Canada, with an aggregate of over 500,000 unique shareholders. The platform, which assists its clients in tracking and interacting with their shareholders, has rapidly become an essential digital tool for equity issuers seeking to broaden their shareholders’ registers during a largely unprecedented time in global markets.

SRAX also seized the opportunity to announce that it had raised $13 million through the sale of convertible debentures and equity warrants (http://nnw.fm/j6F7i), with the proceeds of the capital-raising exercise to be used to fund Sequire’s rapid growth. With client numbers growing by a remarkable 27% over the first six months of the year, the investor intelligence platform has seen its ability to better understand which types of investors are willing to buy different stocks become increasingly defined, thereby enabling Sequire to better serve its clients.

“On Thursday, we announced a capital raise of $13M, which we will use in part to fund the rapid expansion of Sequire,” said SRAX CEO and founder Christopher Miglino. “Our clients have seen notable results from the platform and its related services. We’ve also seen a significant increase in the number of clients on the platform with Q2 sales hitting over $2.5M and an additional $3M in the pipeline, with a very high probability of closing in Q3.”

Sequire has launched a number of new initiatives over the past few weeks so as to broaden its overall service offering to its corporate customers. In addition to its revolutionary ‘Stocks for Ads’ initiative (http://nnw.fm/HlJy1), which enables companies to subscribe for Sequire’s services and pay for media campaigns in exchange for stock, thus allowing them to conserve their cash reserves at an economically tumultuous time – the company has also recently introduced its Virtual Roadshow feature (http://nnw.fm/etyC7).

With companies unable to carry out their traditional investor relations agendas, digital exchanges with investors have increasingly become a priority for corporate management teams. The Virtual Roadshow feature allows companies to host video and audio meetings with both new investors and existing shareholders, while also allowing them to track their meeting attendees’ investments following the event. With investors progressively resorting to digital means to research and interact with new investment opportunities, Sequire and its diverse portfolio of services appear to be in greater demand than ever before.

For more information, visit the company’s website at www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://nnw.fm/SRAX

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

According to forecasts, the demand within the self-injection devices market is anticipated to grow a great deal in the years to come. This increase can be attributed to a number of factors as the discussion below explores.

Transferring Responsibility to Individuals

Over the years, there has been a growing consensus among experts and researchers that individuals (patients) need to play a bigger role in managing the different health conditions that they are afflicted with. In this regard, innovation efforts have gone towards developing a variety of products that put patients in the driver’s seat, and those products include self-injection devices. This shift is fueling the growth of the self-injection device industry.

The Growing Incidence of Diabetes

As the world’s population becomes more sedentary and switches to a diet that is high in processed carbs, the number of people suffering from diabetes, especially Type 2 diabetes, is exploding. It is not sustainable for a patient to go to hospital each time they need a shot of insulin, so self-injection device makers have devoted energy towards coming up with a variety of products to make it possible for patients to administer these shots while at home or at their workplaces. The population of diabetics alone has done a lot to boost the self-injection devices industry.

Strides in Cardiovascular Research

A lot of patients suffer from chronic conditions that affect the lungs, heart and liver. The latest research in the cardiovascular field has brought to market several liquid injectables which can help patients to have a better quality of life despite suffering from a chronic heart, liver or lung disease. Many of these remedies can be administered using self-injection devices, and this category of patients is contributing towards the growing demand for these devices.

A Spike in Pediatric Diabetes Cases

It’s worth mentioning here that the rising cases of diabetes among children is a major factor worthy of mention beyond lumping them together with the adult population. When a kid develops diabetes, that child is likely to depend on insulin injections for the rest of their life, and the advances in the treatment of this disease mean that we are looking at decades of this individual needing self-injection devices. As any pharmaceutical company will tell you, the repeated use of a treatment modality for years drives market growth, and kids with diabetes are exerting an influence in the growth of the self-injection devices market.

As societies transform, new healthcare challenges are emerging and the existing remedies may not be able to cope. These new realities could explain why players in the biomedical field, such as Genprex Inc. (NASDAQ: GNPX), are working round the clock to develop new technologies that respond to the evolving challenges of managing contemporary diseases.

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Rare diseases have brought a more significant impact on the lives of several people more than AIDS and cancer combined, and statistics show that more than 450 million people are suffering from rare diseases worldwide. These rare diseases have escalated due to lack of education, shortage of improved technologies and infrastructure, which has made the diagnosis of these diseases so challenging. However, the good news is that steps are being taken to improve the diagnosis and treatment of rare diseases worldwide.

The Focus Should Be Changed from North America and Europe to the World

For the last 25 years since rare diseases emerged, little has been done to diagnose rare diseases. Focus has been on North America and Europe, thereby neglecting other countries. According to current data, 160,000-180,000 rare disease patients identified yearly came from Arabic countries and, at the same time, had autosomal recessive diseases. This scenario is attributed to the social norms that see a more significant frequency of same family marriages. Additionally, the family size in Arabic countries is also more significant than that of the two continents. Looking at the problem globally will therefore help to provide more diagnostics and treatment options.

Diagnosing Rare Disease Is a Big Challenge

The genetic makeup of different ethnicities is one major factor that should be taken into consideration when diagnosing rare diseases. For example, “a mutation in a Mongolian population might not have any functional consequence but the same mutation might have a big consequence and cause a disease in Caucasian populations.” This implies that thorough interpretation and analysis of medical information is essential to enable proper diagnosis. Sequencing a genome is not challenging; the difficulty lies in the accurate interpretation of the available information. Adequate handling of data is critical to avoid the misdiagnosis of patients.

Data Collection and Analysis Should be More Efficient

The collection of data from various ethnicities for the diagnosis of thousands of patients with the same disease should be coordinated globally. Furthermore, combining genetic testing with metabolomics and proteomics has interpreted data as accurate as possible. The multi-omics approach can give the medical community a better understanding of whether a given mutation may cause functional consequence on a metabolite level. To make the diagnostic process easy, it is important to come up with a system that permits doctors to simplify the sample collection process.

Global Awareness for Rare Disease on Rare Disease Day

Rare Disease Days have been organized since the founding of CENTOGENE by its founder Rolf and his team. On February 29 this year, the first global event was held in three cities around the world in Berlin, Mexico City, and Lahore. Rare Disease Day is always used by CENTOGENE to raise awareness and share information on rare diseases with doctors, scientists’ organizations, patients, and the general public.

The Future of Rare Diseases Lies on the Heart of Innovation

The rare disease space is experiencing a lot of innovation from pharmaceutical companies, and innovations like CRISPR and RNA silencing technology are changing the rare disease landscape. However, the high cost of these innovative drugs is an enormous burden on health care systems globally. These high costs need to be brought down, and the challenge of diagnosis and treatment of rare diseases will be a thing of the past. Entities like Predictive Oncology (NASDAQ: POAI) have clearly taken this challenge seriously and are doing their part to make diagnostics more reliable and affordable.

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

NetworkNewsWire Editorial Coverage: With safety, security and personal protection more tenuous than ever, groundbreaking technology sets sector pioneers as clear industry leaders.

A global pandemic stoked by national protests and riots has created a world where fear and uncertainty run rampant. Enforcing national, state and local directives as well as providing security and protection for essential services such as hospitals and community municipalities has become increasingly important — and increasingly dangerous. Companies operating in the security industry recognize the growing demand for change and are eager to provide solutions. A global pioneer in the development of autonomous security capabilities, Knightscope, Inc. (Profile) looks to disrupt the $500 billion security industry with its patented technology that combines self-driving technology, robotics and artificial intelligence. Knightscope’s Autonomous Security Robots (“ASR”) provide 24/7/365 security and have been proven to enhance safety at hospitals, logistics facilities, manufacturing plants, schools, and corporations.

Wrap Technologies Inc. (NASDAQ: WRTC) is seeing an increased demand from U.S. law enforcement agencies for its exclusive BolaWrap(R), which enables police officers to safely and humanely restrain resisting subjects from a distance without inflicting pain. Axon Enterprise Inc. (NASDAQ: AAXN) has launched a mobile app for body cameras that features remote livestreaming and critical real-time alerts. ShotSpotter Inc. (NASDAQ: SSTI) reports that since the city of Miami adopted its unique ShotSpotter program in 2014, the city’s homicide rate has plummeted by 35% and gunshot incidents as an activity have been reduced by about 50%. And Tesla Inc. (NASDAQ: TSLA), a strong player in the autonomous, self-driving vehicle sector, says a significant update of its Autopilot driver-assist software will be released in the next two to four months.

• Knightscope, Inc. chosen by IBN to spotlight in inaugural Stock2Me podcast.
• Knightscope ASRs are designed to deliver on two priorities: providing a physical deterrent and gathering data to provide unprecedented situational awareness
• Company inprocess of raising up to $50 million in growth capital as it prepares for a potential public listing. Reg A+ offering to close on July 20, 2020 here.

First-Ever Podcast Features Groundbreaking Company

With security and safety at the forefront of today’s news across the country and even around the world, it’s no wonder that Investor Brand Network (“IBN”) chose a groundbreaking security technology company such as Knightscope, Inc. (Profile)  to spotlight in its inaugural Stock2Me podcast. Designed to be an invaluable source for the latest news and updates on market trends and movers in high-profile industry sectors, Stock2Me Podcast keeps its listeners in the loop by providing in-depth information about the inner workings of the ever-evolving North American markets.

The podcast’s first episode features an insightful interview between podcast host Stuart Smith and Knightscope Inc.’s chairman and CEO William Santana Li. Knightscope offers a unique combination of self-driving technology, robotics and artificial intelligence, explained Li during the podcast.

“The math problem we’re trying to solve is, there’s a million security guards across the U.S. There’s another million Iaw-enforcement professionals,” he said. “They actually need to operate 24/7. At any point in time, only about 500,000 humans are trying to secure 328 million people across 50 states. That math doesn’t work.”

Knightscope security robots are fully autonomous and designed to do basically two things, Li explained: provide a physical deterrent and gather data.

“What does that mean?” he asked. “Well, let’s say you’re driving down the highway, and you see a patrol car on the side. What is your immediate reaction? To pump the brakes. Very similarly, if you’re trying to do something nefarious and it’s 4 o’ clock in the morning and you pull into a hospital parking lot and there’s a five-foot-tall, 400-pound machine roaming around on its own — it’s fully autonomous, there’s no one remote controlling it — the strobe light is going and it says security on it and you have no idea what it does, you’re probably basically going to go and steal the car down the street and not there. And that’s what our clients have been experiencing across the country.”

At the same time, Li explained, the security robots gather as much data information from the environment as possible. “The machine [does] the . . .  monotonous and computational heavy work that no human could possibly do, and then . . . humans do the strategic decision making and enforcement work.”

Federal Purchase to Pave Way

Knightscope customers include malls, corporate campuses, manufacturing plants, logistics facilities, hospitals, law enforcement agencies, schools, cities, casinos, and residential and commercial properties, including 10 Fortune 1000 companies to date. Most recently, the company announced that it had received its first federal purchase order awarded through a General Services Administration (“GSA”) contract.

According to the announcement, the company has a one-year agreement, with the potential of renewing for up to five years total service time, to deploy an autonomous security robot (“ASR”) at an undisclosed location in Texas. Knightscope is optimistic that this contract will pave the way for additional deployments at the more than 170-plus locations managed by the same agency, and that other federal agencies may sign up for ASRs when they see the performance of the initial ASR in Texas.

Determined to Deliver on Mission

With more than 10,000 investors and over $40 million raised since the company began in 2013, Knightscope has firmly established its position as an industry leader in the public safety and security sector. But the company is determined to deliver on its mission to make the United States the safest nation in the world while supporting millions of law enforcement and security professionals across the country.

Consequently, the company is currently in the process of raising up to $50 million in growth capital as it prepares for a possible public listing. Shares are only available through Knightscope’s managing broker-dealer StartEngine, and the company will close its current round of Regulation A+ Investment Offering on July 20, 2020.

“The global security market is projected to expand at over 10% per year and reach over $165 billion by 2025,” StartEngine reports. “As public safety becomes more top of mind, Knightscope believes it is uniquely situated at the cross section of multiple key elements of the security market, like video analytics, which was valued at $1.6 billion in its own right.”

Safest Country in the World

While the Reg A+ offering is important, Li notes that the company’s “end goal and aspiration is to see if we can make the United States of America the safest country in the world. A public listing or an IPO or however you want to do it is not the end goal of the company. It is basically a financing, and that’s it. That’s not the mission of the company.”

“I think long term, you know, my personal aspiration is to build a $30 billion company that kind of looks like a defense contractor,” Li continued. “But instead of focusing on the Department of Defense, we would be focused on the Department of Justice, Homeland Security, the 19,000 law enforcement agencies and the 8,000 private security firms.”

Li concluded his Stock2Me podcast interview by noting that “people are starting to realize that, ‘oh, wow, remote monitoring is actually going to become the norm.’ This would be a very unique way to better secure the places you visit, the places you work, study and play,” he said. “I think for the last seven-plus years, we’ve been pretty much screaming at the top of our lungs that we need to reinvent, reimagine, reinvigorate public safety. I’m glad that finally the entire nation is focused on a fundamental issue. I don’t believe the founders of our country ever expected us to build a society where going to work and going to school or just being in our own community comes with the risk of being shot or killed. We need to provide new tools and a new way to think about Public Safety, and Knightscope is at the forefront of that discussion.”

Providing Much-Needed Answers

The security industry is clearly seeking solutions. Savvy companies are stepping up to provide much-needed, innovative answers.

Wrap Technologies Inc. (NASDAQ: WRTC) recently announced that more than 100 agencies had requested BolaWrap demonstrations or training just last month, with an additional 36 agencies applying for grant assistance since the June 4 debut of the company’s Grant Assistance Program. “Agencies have been reevaluating their use of force methods and tools during encounters with subjects who need to be detained,” said Wrap Technologies COO Mike Rothans, who noted that the company’s “remote restraint device is the only tool on an officer’s belt designed to restrain a noncompliant subject without inflicting pain.”

A global leader in connected public safety technologies, Axon Enterprise Inc. (NASDAQ: AAXN) has created a new app that delivers advanced situational awareness for support teams and helps make officers and communities safer. Axon said the industry’s first real-time mobile application allows law enforcement to use a mobile device to remotely view livestreamed Axon Body 3 camera or Axon Air drone footage. The Axon Aware app is bundled with and available at no additional cost for the company’s current OSP7+ subscription plan customers, as well as a la carte customers who have purchased Aware/Aware+ or Axon Air.

ShotSpotter (NASDAQ: SSTI) provides acoustic gunshot detection and precision-policing solutions to help law enforcement officials and security personnel prevent and reduce gun violence and make cities, campuses and facilities safer. The company’s flagship product, ShotSpotter Flex(TM), is the leading gunshot detection, location and forensic analysis system, and is trusted by more than 100 cities. In addition, the company’s ShotSpotter Missions(TM) uses artificial intelligence-driven analysis to help strategically plan patrol missions and tactics for maximum crime deterrence.

Finally, Tesla Inc. (NASDAQ: TSLA) CEO Elon Musk announced on Twitter about the company’s rewritten version of Autopilot. The rewrite is expected to bring a host of new functionality. With Tesla building its most affordable car yet, Tesla continues to make products accessible and affordable to more and more people, ultimately accelerating the advent of clean transport and clean energy production. “Electric cars, batteries, and renewable energy generation and storage already exist independently, but when combined, they become even more powerful — that’s the future we want,” the company states.

The traditional practices of the security industry have remained virtually the same for years. Today’s society, however, is demanding change, as the safety and protection of every individual is becoming a top priority.

For more information, please visit Knightscope, Inc.

About NetworkNewsWire

NetworkNewsWire (“NNW”) is a financial news and content distribution company, one of 40+ brands within the InvestorBrandNetwork (“IBN”), that provides: (1) access to a network of wire solutions via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution via IBN millions of social media followers; and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience comprising investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork

DISCLAIMER: NetworkNewsWire (NNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by NNW are solely those of NNW. Readers of this Article and content agree that they cannot and will not seek to hold liable NNW for any investment decisions by their readers or subscribers. NNW is a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, NNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

NNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and NNW undertakes no obligation to update such statements.

Although plenty of states have now legalized medical and recreational marijuana in various forms, it still carries a lot of stigma. Most employers are uncomfortable with employees consuming cannabis, even during non-work hours, and plenty of sports organizations do not allow their athletes to use marijuana. The military has a harsh stance on marijuana too, and veterans who admit to using marijuana even in a legal state can be barred from reenlisting.

A measure introduced two years in a row by Rep. Ruben Gallego and approved by a Congressional Committee would help resolve the issue. The measure would allow heads of military branches to grant waivers on a case by case basis to service members seeking to reenlist who admit to consuming cannabis or were convicted of a misdemeanor marijuana offense. Text from the measure states that “within 90 days of the enactment of the bill, the Secretary of Defense shall prescribe regulations that permit any Secretary of a military department to grant a reenlistment waiver to a covered person if the secretary determines that the reenlistment of that covered person is vital to the national interest.”

It further states that service members who have “admitted to or been convicted by a court of competent jurisdiction of a single violation of any law of a state or the United States relating to the use or possession of cannabis” would be covered as long as it was a misdemeanor offense and did not occur while they were on active duty. “Smoking pot just once shouldn’t prevent a patriotic American from fighting for our country. We need to finally exercise some common sense when it comes to our marijuana policies, and I’m glad my amendment will lead us in that direction,” says Rep. Gallego.

This is the second year in a row Rep. Gallego has filed a measure to allow service members who admitted to smoking marijuana to reenlist. At the House Armed Services Committee meeting, he stated that it was important to fundamentally rethink the military’s enlistment policies regarding marijuana, “especially given our nation’s recruitment crisis.” “Our nation’s views on marijuana use are changing, and the services have changed their recruitment process accordingly. The services can, where appropriate, grant waivers to former users of marijuana who want to serve their country in uniform,” he said at the time.

This year’s measure was adopted as part of a package with several other amendments to the National Defense Authorization Act by the House Armed Services Committee on Wednesday. As it heads to the House Floor, it will be attached to a large scale defense spending bill for the next fiscal year.

It would be interesting to hear what industry actors like Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) have to say about the likelihood of this amendment making it through both legislative chambers.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

A University of Oxford spinout focusing on genomics will benefit from a seed round of $11.4 billion. It aims at improving cancer detection by measuring epigenetic changes to tumor DNA circulating in a patient’s blood. The oversubscribed seed funding round was pioneered by Oxford Sciences Innovation. It is a local early-stage investment enterprise connected to the University of Oxford.

Base Genomics will make use of technology developed at the University of Oxford called TAPS. TAPS is responsible for detecting epigenetic methylation of DNA at a single-base level. DNA methylation is a method in which cells can switch off specific genes without changing the DNA’s base code. DNA methylation can also be disrupted by different types of cancer. That way, physicians can find early signs of disease by screening for abnormally methylated DNA shed into the bloodstream by solid tumors.

DNA methylation is the most efficient biomarker for early disease detection. A firm called Grail secured $1.5 billion to come up with a blood test for early-stage cancer detection, and after testing different methods in three years it came to the conclusion that detecting DNA methylation generates efficient results, according to Oliver Waterhouse, Co-founder, and CEO of Base Genomics. According to Waterhouse, DNA methylation is one of the most stable source of epigenetic information (a vital trait in diagnostics).

Until today, the incisive reading of the epigenetic code has been complicated. Ancient methods destroyed the sample, making it unusable for subsequent sequencing of the genome and limiting clinical sensitivity. The Base Genomics TAPS method is very efficient in reading these codes in a precise way while keeping the sample intact. It therefore allows physicians to perform more tests with the same amount of DNA sample.

Early-stage cancer identification through non-invasive liquid biopsies, such as urine or blood samples, is the Holy Grail in cancer diagnostics. Moreover, sampling a suspected tumor directly can be stressful and time-consuming for patients. However, biomarkers such as DNA and proteins linked to cancer can now easily be detected from extracted blood samples through this new technology. Additionally, liquid biopsies are becoming new gold mines in the detection of disease.

Base Genomics is however not only limited to liquid blood biopsies; the company is also looking to expand its diagnostics beyond cancer. Waterhouse, the CEO of Base Genomics, adds that they can use their new technology on saliva and urine. They have also been talking with other collaborators on using their technology on cerebrospinal fluid samples in diagnosing different neurodegenerative disorders, such as Alzheimer’s.

Other companies other than Base Genomics are monitoring the epigenetic signs of the disease. Bio-techne, a US-based company, is one of the major players in the liquid biopsy field and it has come up with a non-invasive liquid biopsy for the detection of prostate cancer. The method focuses on analyzing the RNA found in exosomes in urine, and is capable of discriminating between high-grade and low-grade prostate cancer. Furthermore, another firm in the UK called Oxford Biodynamics, has been applying an epigenetic method that looks at the structure of the chromosomes to diagnose Huntington’s disease.

All these exciting developments mean that biomedical companies like Genprex Inc. (NASDAQ: GNPX) are in good company since lots of entities are taking part in making diagnostics more accurate and timely.

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

• Nuclear increasingly seen as critical energy in post-pandemic world
• UUUU plays leading role in the U.S. nuclear industry, producing more than one-third of country’s uranium over past 15 years
• Energy Fuels provides investors with compelling growth potential underpinned by industry-leading production assets, robust balance sheet

Energy Fuels (NYSE American: UUUU) (TSX: EFR), the largest uranium producer in the United States and the leading conventional producer of vanadium, appears well positioned to capitalize on the recent attention that nuclear power has attracted, both in the United States and abroad. A recent push for nuclear power by the International Energy Association (“IEA”) and OECD Nuclear Energy Agency, two major international organizations, recognizes immense benefits of this energy source for both economic recovery and energy supply resilience in the post-COVID19 world.

According to the IEA, nuclear power has been one of the largest contributors to carbon-free electricity with the considerable potential to contribute to power sector decarbonization. In its recent World Energy Outlook Special Report on Sustainable Recovery, the agency reported that investing in nuclear energy, particularly in existing power plants, is one of the measures set out to support clean energy technologies during the COVID19 economic recovery (http://nnw.fm/Yc8yW). The report notes that extending the operations of existing nuclear plants will support job creation and the prevention of more emissions per GW than other low-carbon options.

In a similar tone, the OECD Nuclear Energy Agency recently published a series of policy briefs (http://nnw.fm/cwjV8) that investigate the role of nuclear energy in the post-pandemic economic recovery covering four themes: building resilience of electricity infrastructures, high-quality job creation, cost-effective decarbonization and unlocking finance for nuclear energy infrastructure.

In a statement following the release of the briefs, the agency stated that the COVID19 pandemic had made a significant impact on the global economy and the energy sector underlining the importance of electricity resilience and reliability during major disruptions. It is becoming increasingly clear that stimulus packages put in place by governments around the world have the opportunity to foster energy systems that not only contribute to economic recovery but also meet long‑term environmental goals and energy security, said the agency. Nuclear energy can play a key role in post-COVID19 economic recovery.

The pandemic may be an additional impetus for an already growing industry. The global demand for clean energy is increasing, with nuclear energy emerging as an excellent option. With power plants that operate 24/7, nuclear is a reliable, stable and affordable energy source with zero carbon emissions and air pollution. In the United States, nuclear supplies 20% of all electricity and 55% of all clean energy (http://nnw.fm/z0XKP). At the same time, major uranium producers are shut down due to the pandemic, including global leader Kazakhstan, which produces 40% of the world’s uranium, squeezing an already tight market.

With more uranium production facilities and capacity, as well as more in-ground resources than any other company in the country, UUUU has produced more than one-third of all U.S. uranium over the past 15 years (http://nnw.fm/5yeCI). The Colorado-based diversified miner has been focused on building a rock-solid balance sheet through a strategy of reducing the debt burden over the past several years. UUUU has recently announced the plan to pay off half of its debt by mid-July 2020, expecting to become debt-free by the end of 2020 (http://nnw.fm/k1RzY). The company is also seeking to bring rare earth element production back to the U.S. With an unparalleled ability to swiftly increase low-cost U.S. uranium production, Energy Fuels is well-positioned to capitalize on the growing role of the nuclear energy in the years to come.

For more information, visit the company’s website at www.EnergyFuels.com.

NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://nnw.fm/UUUU

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

• Predictive Oncology announced the acquisition of Soluble Therapeutics Inc. & BioDtech Inc.
• Acquired companies seek to enhance drug development process through the optimization of protein solubility and stability as well as through detection, removal of endotoxins
• The companies were acquired for consideration amounting to 125,000 common shares and waiving of $1.07 million promissory note issued by parent company, InventaBioTech
• Predictive Oncology seeks to build out its precision medicine business line, aimed at helping clinicians individualize cancer treatment

Predictive Oncology (NASDAQ: POAI), a knowledge-driven medicine company that focuses on applying data and artificial intelligence (“AI”) to cancer personalized medicine and drug discovery, announced that it had completed the acquisition of Soluble Therapeutics Inc. and BioDtech Inc. (http://ibn.fm/ccEdD). The company revealed that it had purchased the assets of Soluble and BioDtech, including certain intellectual property relating to contract research organization (“CRO”) services and equipment from parent company InventaBioTech for a total consideration of 125,000 shares of common stock. As part of the transaction, Predictive Oncology also waived all of the remaining amounts due and payable to the company under a secured promissory note of InventaBioTech in the principal amount of $1,070,000 relating to advances made by the company in 2017.

The acquisition of Soluble Therapeutics and BioDtech marks a new step in Predictive Oncology’s journey towards building out its precision medicine business, following its acquisition of its Helomics arm in April 2019. Soluble Therapeutics, which was founded in 2008 with the aim of commercializing technology licensed from the University of Alabama at Birmingham, seeks to enhance the drug development process by rapidly optimizing protein solubility and stability. Meanwhile, BioDtech develops and markets a line of reagents and systems for the detection, neutralization and removal of endotoxin for researchers in the bioresearch and bioprocess fields.

“These two acquisitions meaningfully expand revenue and monetization prospects for our precision medicine business,” said Predictive Oncology CEO and director Dr. Carl Schwartz (http://ibn.fm/4Nk9J). “First, the Soluble Therapeutics assets increase the company’s capabilities to provide services for the pharmaceutical and biotech industries and predict and provide the best formulation with the highest concentration and the most stable solution for protein and peptide-based drugs. Second, the company’s purchase of BioDtech’s assets provides it with ownership over BioDtech’s successfully developed test used to ‘unmask’ endotoxins, which allows a monitoring physician to perhaps change the strategy of treatment or treat the patient with antibiotics. These acquisitions will allow Predictive Oncology to further maximize opportunities within the company’s precision medicine business.”

Predictive Oncology is bringing precision medicine, or tailored medical treatment using the individual characteristics of each patient, to the treatment of cancer. Through its Helomics division, the company leverages its unique, clinically validated patient derived (“PDx”) smart tumor profiling platform to provide oncologists with a roadmap to help individualize therapy. In addition, the company is leveraging artificial intelligence and its proprietary database of over 150,000 cancer cases tumors to build AI-driven models of tumor drug response to improve outcomes for the patients of today and tomorrow.

For more information, visit the company’s website at www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

• SRAX derives consumer data from BIGtoken platform that compensates over 16 million users from more than 30 countries for access to their data
• BIGtoken provides brands with ability to target and access specific niche groups across 25,000 unique points of segmentation

The business of big data is evolving to benefit both consumers and marketers as demonstrated by the success of SRAX (NASDAQ: SRAX), a technology company focused on digital marketing and consumer data management. The Company’s BIGtoken platform compensates over 16 million users with cash or gift cards when they opt in to give access to their data while concurrently creating valuable data sets that can be accessed by marketers for a fee.

“Big marketers are really interested in this,” said SRAX CEO and founder Christopher Miglino in an interview on the LA Weekly Podcast with Brian Calle (http://nnw.fm/2itUl). “They don’t want to buy bad data anymore. They want to buy data from consumers that have said ‘yes, you have the right to market to me’, so we’ve found ourselves in a unique spot.”

SRAX’s tools deliver a digital competitive advantage for companies in several verticals that include consumer goods, investor relations, luxury, and lifestyle. The Company’s technology unlocks data to reveal brands’ core consumers and their characteristics across several marketing channels by integrating all aspects of the advertising experience into a single platform. Besides giving access to marketers for a fee, SRAX also engages in the sale of specialized data sets across several verticals.

“Our primary focus is figuring out ways to monetize different data sets. We had a business a few years ago where we aggregated data on doctors in the country and then we sold that data,” said Miglinio, referring to SRAX’s healthcare vertical, SRAX MD, that sold for a $43.5 million consideration while allowing SRAX to retain a 31% ownership.

Investor relations is another key area for SRAX that has increased in importance during these unprecedented economic times, elevating demand for virtual investor relations platforms. Through SRAX’s Sequire platform, CEOs & CFOs of publicly traded companies are now able to monitor the trading behaviors of their investors while the investors in turn are kept informed on corporate prospects.

The power of big data to meet the demands of the increasingly demanding and competitive economic landscape is exemplified by SRAX’s services that give clients the ability to target and access specific niche groups across 25,000 unique points of segmentation. The platform’s unique interface gives users the power to submit specialized queries that include location and purchase history.

Besides serving clients on both sides of the data trade, SRAX also gives back to the community by allowing BIGtoken users to donate their earnings to charity through its partnerships with several high-profile, nonprofit associations. Through the program, BIGtoken users are able to support efforts put forward by the American Heart Association, HealthCorps and The ALS Association.

For more information, visit the company’s website at www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://nnw.fm/SRAX

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

On July 1, New Jersey is slated to reduce the sales tax on medical marijuana from 6.625% to 4%. This move is the first in a series of measures that will see state sales taxes removed entirely within a space of three years. On July 1 next year, the tax will reduce to 2% and the following year (July 1, 2022) will see the reduction to a 0% state sales tax.

However, the sales tax reforms which roll out tomorrow don’t mean that buyers of medical marijuana will not pay any taxes on their purchases. Municipalities within New Jersey are still allowed to impose a 2% sales tax within their jurisdictions, but so far, no town has invoked this provision to levy the tax.

The plan to phase out sales taxes on medical marijuana were part of the Jake Honig Compassionate Use Act enacted into law last year. The bill was named after Jake Honig, a 7-year old kid from Howell who had an inoperable tumor in the brain. Only medical marijuana gave him any relief until he passed in 2018.

Activists raised an uproar about the sales taxes imposed by the state on medical marijuana. This outcry was prompted by the fact that prescription medications are exempted from state sales tax. The activists therefore wanted medical marijuana to be regarded in the same way since it is a prescription medicine in New Jersey.

While the bill was being debated in the state legislature, several lawmakers called the sales tax “criminal” since working class and poor families would suffer an added burden while acquiring the medicine they need.

Currently, more than 77,000 people are registered on the state’s medical marijuana program. However, supply chain problems and the resulting prohibitive prices (medical marijuana can cost approximately $500 an ounce) have plagued the progress of the sector.

As the tax cuts kick in, an ounce of medical marijuana will drop to about $469.15. This will bring some relief to patients, and as the supply issues are sorted, prices could drop even further.

At the moment, only nine clinics are open to sell medical pot to patients across the state. Other locations that were pre-approved haven’t opened their doors to customers due to ongoing legal battles.

In November, New Jersey voters are slated to vote on a ballot measure that could see recreational marijuana legalized. If the bill passes, dispensaries will be allowed to sell recreational marijuana to adults who are 21 or older.

The reduction of the state sales tax on medical marijuana is likely to be welcomed by the entire industry, including Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) since it makes products more affordable for patients.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

NetworkNewsWire Editorial Coverage: Despite lockdowns, creative data analytics and digital marketing deliver incredible results.

As the nation’s economy slammed shut due to the pandemic, certain sectors seemed to defy the severity of the situation. The digital world seemed to defy gravity, generating ever more interest and expediting uptake out of necessity. A recent press release from SRAX Inc. (NASDAQ: SRAX) (SRAX Profile) is a prime example of such gravity-defying action and may be a harbinger of what’s to come. Leveraging in-depth investor intelligence and big data analytics, SRAX uses proprietary technology to creatively unlock and utilize data in new powerful ways to create a new nexus of opportunity between public companies, financiers, investors and traders. SRAX just released news on Sequire, the company’s innovative technology platform for comprehensive investor intelligence, corporate communications and shareholder retention and acquisition. From launch just over a year ago, Sequire has grown its client base to over 75 publicly traded companies, amassing an aggregate 500,000+ active investors and traders  as sales have exploded in Q2 2020. What makes Sequire so attractive with such rapid uptake is that for the first-time public companies can monitor investors and activate media campaigns to engage existing investors and attract new ones. SRAX’s technology delivers public companies unparalleled insights into investors’ behaviors and trends and newfound ability to use those insights to engage investors across various marketing channels. Leveraging data and resources from Broadridge Financial Solutions Inc. (NYSE: BR), a leading provider of communications and data and analytics solutions, Sequire has attracted public companies across a wide spectrum of industries and delivered notable results from its platform for such diverse companies as Genius Brands International Inc. (NASDAQ: GNUS), a children’s entertainment media company; Can B Corp. (OTCQB: CANB) a health & wellness company; and Wrap Technologies Inc. (NASDAQ: WRTC), an innovator of modern policing solutions.

Accelerated Uptake

The adoption of technology and the digitization of business has been underway for decades. Changes were evolving long before coronavirus, but the pandemic hypersonically accelerated the evolution. Companies that were obliquely considering digital solutions a few years ago are now embracing them as part of the new normal, establishing business relationships for a long-term digital future. Whether through Zoom meetings, virtual conferences or digital marketing, companies in nearly every industry are pivoting to adapt to the crisis. The virus has hastened the digital transition so fast that customers across every sector are flocking to technology solutions as digital platforms reap the benefits. This transition to technology is no passing fad and is expected to permanently alter the way business is conducted and social interactions occur. Nowhere is this transition more needed or welcomed than in the complex interactions between public companies and their current and future shareholders. Roadshows and investor conferences are suddenly lumbering dinosaurs while virtual meetings lack sizzle and have limited appeal. Innovative new strategies and creative big data solutions are at the heart of establishing a new paradigm in investor intelligence, and corporate communications and will set the standard for decades to come.

Data Centric Solutions

It’s a common understanding that data is collected and analyzed, but data alone is useless until it’s been parsed and massaged in some manner to create actionable intelligence. The optimization and monetization of data is a multibillion-dollar global business – data and business analytics solutions reached $166 billion in 2018, and it is projected to explode to $260 billion in just two years.  SRAX (NASDAQ: SRAX) (SRAX Profile), a rapidly growing, innovative consumer data management technology company, is carving an enviable niche in this explosive market. SRAX uniquely unlocks the value of data, integrating all aspects of the digital marketing and advertising experience, including verified consumer participation, all into one platform. Through its Sequire technology platform, SRAX is monetizing datasets and growing recurring revenue streams by delivering a digital competitive advantage for clients. Recent news at Sequire offers crystal clear insight into the company’s parabolic growth potential. Using proprietary processes, unique data management technology and digital marketing acumen, Sequire has experienced incredible growth from its launch just over a year ago, expanding its client base to over 75 publicly traded companies in the U.S. and Canada. Sequire posted record sales of over $2.5M in Q2 2020, servicing an aggregate of 500K+ investors and traders that issuers have on the platform. These ballooning numbers indicate an accelerated uptake of Sequire’s unique investor relations services, long a stumbling block for publicly traded companies.

Some of this accelerated uptake may be attributed to the pandemic, but platform efficacy is paramount – clients come and stay because it works, delivering new digital competitive advantages. Through Sequire, public companies can now monitor and track retail and institutional investors then activate media campaigns to engage existing investors and simultaneously attract new ones. Sequire can identify traits of current investors and is then able to market directly to subgroups to attract liked minded shareholders. Public companies never had it so good, especially ones providing niche products services. This has long been the bane of public companies – how to effectively interact and communicate with current shareholders and—even more importantly—how to appeal to and attract new shareholders. Never before has such an effective solution been provided to the investor relations dilemma faced by publicly traded companies.

This news comes on the heels of last week’s eyepopping revelation that SRAX had entered into a definitive securities purchase agreement led by existing institutional investors for the purchase and sale of an aggregate of $13 million senior secured convertible debentures to fund the rapid expansion of Sequire. Pegged at an above-market fixed conversion price of $2.69, the deal appears to be another strong vote of confidence from institutional investors in the viability and future of SRAX’s technology as well as an endorsement of the market value of data analytics and digital marketing.

“On Thursday, we announced a capital raise of $13M, which we will use in part to fund the rapid expansion of Sequire,” said SRAX CEO and founder Christopher Miglino. “Our clients have seen notable results from the platform and its related services. We’ve also seen a significant increase in the number of clients on the platform with Q2 sales hitting over $2.5M and an additional $3M in the pipeline, with a very high probability of closing in Q3.”

To translate, Sequire has a high probability of reaching a 200% quarter-over-quarter increase in sales in the midst of a crippling global pandemic – hard to imagine any stronger validation of efficacy and accelerated uptake of SRAX’s technology and services.

In new powerful ways, public companies using Sequire now track their investors’ behaviors and trends and use those insights to engage current and potential investors across multiple marketing channels. By uniquely marrying data management and digital marketing, Sequire unlocks investor behaviors and trends, even providing public companies the ability to identify who is buying and selling stock. Then, using these newfound detailed insights, these companies can pique and capture the interest of existing investors as well as attract new investors.

Sequire gives public companies the power to:

• Monitor shareholders’ behaviors from a company’s data sets over time
• Analyze activity from market makers and see the biggest gains and losses
• Uncover trends over time from buyer and sellers
• Track ROI from investor relations programs
• Assign shareholder credit to investor relations firms
• Turn real-time conference visitor data into targeted cross-channel ads
• Reach potential investors based on current stock buyer behaviors and trends
• Target current stock buyers to promote a higher return from existing relationships

Putting power into finger tips, Sequire also offers an multi-feature innovative mobile APP and more information can be found at MySequire.com.

SRAX has an extensive background and acumen in data management and digital advertising as well as deep understanding how to strategically interact with different brands. The rapid acceptance and adoption of SRAX’s product offering in the midst of a pandemic, strong institutional investor support, and the accelerated embracement of digital solutions definitely makes SRAX one to watch.

Just a Few of a Growing Number

Broadridge Financial Solutions, Inc. (NYSE: BR) is a $4 billion global fintech leader, provides investor communications and technology-driven solutions for broker-dealers, banks, mutual funds and corporate issuers globally. Broadridge’s investor communications, securities processing and managed services solutions help clients reduce their capital investments in operations infrastructure, allowing them to increase their focus on core business activities.

Genius Brands International, Inc. (NASDAQ: GNUS) is a leading global media company that develops, produces, markets and licenses branded children’s entertainment properties and consumer products for media and retail distribution. The company distributes its content worldwide in all formats, as well as a broad range of consumer products based on its characters. The Genius Brands Network currently reaches 80 million U.S. households with continued expansion planned both in the U.S. and internationally.

Wrap Technologies, Inc. (NASDAQ: WRTC) is an innovator of modern policing solutions. The company’s BolaWrap product is a patented, hand-held remote restraint device that discharges an 8-foot bola style Kevlar(R) tether to entangle an individual at a range of 10-25 feet. The small but powerful BolaWrap 100 assists law enforcement to control encounters safely and effectively.

Can B Corp. (OTCQB: CANB) is a health & wellness company providing some of the highest grade and purity cannabidiol (CBD) products available under multiple recognized brands. “Sequire is an essential tool for any CEO to understand what is going on with their stock and for their ability to communicate with their investors and find new ones,” said Can B Corp. CEO Marco Alfonsi. Can B utilizes multi-channel distribution to reach consumers, including medical facilities, doctor offices, retailers, online and direct. The company owns and operates an R&D and production facility in Lacey, WA, and Green Grow Farms, a licensed hemp grower and cultivator in New York.

For more information on SRAX Inc., please visit SRAX Inc. (NASDAQ: SRAX).

About NetworkNewsWire

NetworkNewsWire (“NNW”) is a financial news and content distribution company, one of 40+ brands within the InvestorBrandNetwork (“IBN”), that provides: (1) access to a network of wire solutions via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution via IBN millions of social media followers; and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience comprising investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork

DISCLAIMER: NetworkNewsWire (NNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by NNW are solely those of NNW. Readers of this Article and content agree that they cannot and will not seek to hold liable NNW for any investment decisions by their readers or subscribers. NNW is a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, NNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

NNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and NNW undertakes no obligation to update such statements.